News
Tramway Venture Partners
Tramway Ventures awarded Early-Stage VC Firm of the Year by MedTech World North America 2026
Tue, 12 May 2026 More than 5,000 public votes, combined with the insights of an independent steering committee, helped determine the winners of the awards presented during Day 0 of…
How The BioScience Center is helping New Mexico’s tech industry thrive
Technology continues to advance extremely quickly across the globe, and that is no different here in New Mexico. Some of the major growth that the Land of Enchantment is seeing…
Tramway Ventures lands state boost for new $40M fund
By Jacob Maranda – New Mexico Inno Reporter September 19, 2023, 05:12pm MDT There could soon be a lot more venture capital flowing into New Mexico companies thanks to…
Armonica Technologies
UNM Technology Accelerates Genomic Sequencing
Today, DNA sequencing is a tortuous process that often takes days and sometimes weeks to read a full human genome, but University of New Mexico researchers may have found a…
Pushing the Boundaries of DNA Sequencing
A young company developing technology created at the University of New Mexico (UNM) is on a mission to disrupt the landscape of DNA sequencing. Armonica Technologies, LLC, is developing a…
- « Previous
- 1
- 2
- 3
- 4
BennuBio
BennuBio acquired by California firm
The Albuquerque company, founded in 2018, will maintain a presence in the city Albuquerque Journal |12 Oct 2025 |BY NATALIE ROBBINS JOURNAL STAFF WRITER Natalie Robbins covers the economy and…
Precision Cell Systems Acquires BennuBio to Enter the 3D Cell Culture Market
LIVERMORE, Calif., Oct. 1, 2025 /PRNewswire/ — Precision Cell Systems (PCS) today announced the acquisition of BennuBio, marking a significant entry into the rapidly growing 3D cell culture market. According…
BennuBio Receives SLAS 2022 Ignite Award
February 27, 2022 BennuBio announced it received the Society for Laboratory Automation and Screening (SLAS) prestigious Ignite award at SLAS’s annual International Conference and Exhibition in Boston, MA on February…
Circular Genomics
Global Alzheimer’s Platform Foundation Announces Strategic Collaboration and Partnership with Circular Genomics for the Transformative Bio-Hermes-001 Study
Washington D.C., May 28, 2026 – The Global Alzheimer’s Platform Foundation® (GAP) is pleased to announce a collaboration with the Circular Genomics, a biotechnology company revolutionizing neurological and psychiatric precision medicine,…
Circular Genomics and Vitazi.ai Forge Strategic Alliance to Develop First-in-Class Multimodal Workflow for Early Alzheimer’s Detection
SAN DIEGO, April 29, 2026 /PRNewswire/ — Circular Genomics, the precision neurology leader pioneering circular RNA (circRNA)-based molecular diagnostics, today announced a strategic alliance with Vitazi.ai, an innovator in AI-powered…
Circular Genomics Strengthens Scientific Advisory Board with the Addition of Esteemed Alzheimer’s Experts
Michael Weiner, MD and Timothy Hohman, PhD, bring decades of experience in neurological diseases with a focus on Alzheimer’s disease SAN DIEGO, Dec. 8, 2025 /PRNewswire/ — Circular Genomics, a…
WaveDyn Vision
Senior Ophthalmology Executive Thomas A. (Tom) Dunlap Joins WaveFront Dynamics Inc. as an Independent Member of the Board of Directors to Support the Company’s Ongoing Commercialization and Broader Strategic Initiatives
ALBUQUERQUE, N.M.–(BUSINESS WIRE)–WaveFront Dynamics Inc. (WDI), a venture backed company and pioneer in wavefront sensing technology for use in measuring and perfecting visual performance, today announced the appointment of Tom…
WaveFront Dynamics Inc. Launches WaveDȳn® Vision Analyzer
ALBUQUERQUE, N.M.–(BUSINESS WIRE)–WaveFront Dynamics Inc., an ophthalmic medical device company, announced today the commercial launch of its dynamic aberrometry measurement system, the WaveDyn Vision Analyzer. The WaveDyn Vision Analyzer (pronounced…
WaveFront Dynamics Inc. Initiates $3mm Series A Round to Fund Continued Development of Dynamic Wavefront Measurement System for Vision Correction
ALBUQUERQUE, N.M.–(BUSINESS WIRE)–WaveFront Dynamics Inc. (WaveDyn™), an early stage ophthalmic medical device company, today announced the first close of a $3 million Series A financing round. The round was led by…
Vitazi.ai
Circular Genomics and Vitazi.ai Forge Strategic Alliance to Develop First-in-Class Multimodal Workflow for Early Alzheimer’s Detection
SAN DIEGO, April 29, 2026 /PRNewswire/ — Circular Genomics, the precision neurology leader pioneering circular RNA (circRNA)-based molecular diagnostics, today announced a strategic alliance with Vitazi.ai, an innovator in AI-powered…
VSP Vision Innovation Challenge Winners Revealed at Vision Expo West 2025
LAS VEGAS—Vision Expo West, produced by RX and The Vision Council, in collaboration with VSP Vision, a leader in health-focused vision care, and MATTER, the premier health care incubator and…
Vitazi.ai Announces Partnership with Eye Associates of New Mexico to Advance AI-Powered Retinal Screening
SANTA FE, N.M., Feb. 12, 2025 /PRNewswire/ — Vitazi.ai, Inc., a key leader in Oculomics, is pleased to announce an agreement with Eye Associates of New Mexico, the largest ophthalmology…